All About Positive Health

Just another Blog Engage Bloggers Club weblog

  • RSS ClinicianOnNet

    • Links for 2012-03-28 [Digg] March 29, 2012
      Bleeding During Catheterization of Male Urethra I was called at 10.30 PM to attend a case of bleeding from urethra following urethral catheterization in a semiconscious male, admitted to the medicine ward. I went and saw a healthy male in sixties bleeding from urethra. The foley's catheter, a narrow silicon tube used for draining the retained urine was […]
    • Links for 2012-03-23 [Digg] March 24, 2012
      A Common Blood Pressure Lowering Drug Verapamil may Slow Or Reverse Diabetes A common medication for high-blood-pressure and angina, verapamil, a calcium channel blocker has been seen to protect or reverse diabetes-related death of pancreatic beta cells, those responsible for secretion of insulin; according to a University of Alabama at Birmingham study publ […]
    • A Common Blood Pressure Lowering Drug Verapamil may Slow Or Reverse Diabetes March 24, 2012
      A common medication for high-blood-pressure and angina, verapamil, a calcium channel blocker has been seen to protect or reverse diabetes-related death of pancreatic beta cells, those responsible for... [[ This is a content summary only. Visit my website for full links, other content, and more! ]] […]
  • Get it Delivered to YOU.

    Enter your email address:

    Delivered by FeedBurner

  • Recent Comments

  • Meta


  • 0
    Unique
    Visitors
    Powered By Google Analytics
  • Pages

  • Recently Active Member Avatars

    Member avatar
    Member avatar
    Member avatar
    Member avatar
    Member avatar

Febuxostat and Allopurinol Combination Works Better in Gout

Posted by Dr.Prahallad Panda on June 21, 2010

Gout, an arthritic disease having hall mark of affecting the metatarsophalangeal (MTP) joint, the joint of great toe to the foot; is very painful. Colchicine is the specific drug in acurte phase along with a NSAID such as naproxen. In long term allopurinol is used. The target is to get the urate (Uric acid ) level something below 6mg%. Now researcher say combining a newer drug febuxostat may give better result, though disease flares may not reduce.
Another experimental monoclonal antibody, Canakinumab addition may decrease the flares; said the researchers.
clipped from www.medpagetoday.com
ROME — Gout patients treated with febuxostat (Uloric) at a dose of 80 mg or 120 mg daily saw greater declines in serum urate levels than those treated with allopurinol 300 mg, researchers said here.

At the patients’ final clinic visit, 75% of those treated with febuxostat 80 mg/day achieved urate-lowering to a goal of less than 6 mg/dl, but only 38% of patients taking allopurinol 300 mg/day achieved that goal (P<0.001), according to Michael Becker, MD, of the University of Chicago.

When the researchers looked a further urate lowering, they found that 65% of those on the higher febuxostat dose achieved a serum urate level below 5 mg/day, as did 47% on the lower febuxostat dose and just 13% on allopurinol. The differences between both febuxostat treatment groups and the allopurinol group were again significant at P<0.001.

Despite lower serum urate levels, no differences were observed between treatments for gout flares or reduction of tophi.

  blog it

Leave a Reply



XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>